Dr. Al-Haddad completed his medical residency at Cleveland Clinic in Ohio. Following his gastroenterology fellowship that included advanced endoscopy training at Mayo Clinic in Florida, Dr. Al-Haddad joined Indiana University School of Medicine in 2007 where he also pursued a Master’s degree in Clinical Research from Indiana University and is currently Professor of Medicine. During his tenure at IU, Dr. Al-Haddad served in several roles including the director of advanced endoscopy (2007-2014), and medical director of the IU Pancreas Cancer Prevention Program (2007-2014). Dr. Al-Haddad served as Associate Clinical Director in the division (2016-2019), Clinical Director (2019-2022), interim Division Director (2020-2022) before being confirmed as the Division Director in January 2023 and being named the Naga P. Chalasani Chair of Gastroenterology and Hepatology then. Dr. Al-Haddad also serves as the Chief of Destination (International) services, and has helped grow several new clinical programs (2016-2020) including the Medical and Endoscopic Weight Loss Program, the Innovative and Third Space Endoscopy programs as well as Gastroenterology Hospital Medicine program. Dr. Al-Haddad’s clinical and research interests include pancreas disease, GI cancers and is a world-renowned expert in endosonography and in third space endoscopy. Dr. Al-Haddad mentored dozens of fellows and residents, is well published with over 320 manuscripts (as of April 2025), including 18 Practice Guidelines. He is also the recipient of several research, service and career development grants. Dr. Al-Haddad served as the Governor of the American College of Gastroenterology for the State of Indiana (2019-2025) and currently serves as the Associate Editor for Clinical Gastroenterology and Hepatology, the American Gastroenterological Association (AGA) leading clinical journal.